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Abstract
Naturally occurring canine osteoarthritis represents a welfare issue for affected dogs (Canis
familiaris), but is also considered very similar to human osteoarthritis and has therefore
been proposed as a model of disease in humans. Central sensitisation is recognized in
human osteoarthritis sufferers but identification in dogs is challenging. Electromyographic
measurement of responses to nociceptive stimulation represents a potential means of
investigating alterations in central nociceptive processing, and has been evaluated in con-
scious experimental dogs, but is likely to be aversive. Development of a suitable anaes-
thetic protocol in experimental dogs, which facilitated electrophysiological nociceptive
withdrawal reflex assessment, may increase the acceptability of using the technique in
owned dogs with naturally occurring osteoarthritis. Seven purpose bred male hound dogs
underwent electromyographic recording sessions in each of three states: acepromazine
sedation, alfaxalone sedation, and alfaxalone anaesthesia. Electromyographic responses
to escalating mechanical and electrical, and repeated electrical, stimuli were recorded. Sub-
sequently the integral of both early and late rectified responses was calculated. Natural log-
arithms of the integral values were analysed within and between the three states using multi
level modeling. Alfaxalone increased nociceptive thresholds and decreased the magnitude
of recorded responses, but characteristics of increasing responses with increasing stimulus
magnitude were preserved. Behavioural signs of anxiety were noted in two out of seven
dogs during recordings in the acepromazine sedated state. There were few significant dif-
ferences in response magnitude or nociceptive threshold between the two alfaxalone
states. Following acepromazine premedication, induction of anaesthesia with 1–2 mg kg-1
alfaxalone, followed by a continuous rate infusion in the range 0.075–0.1 mg kg-1 min-1
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Introduction
Osteoarthritis (OA) has been estimated to affect 20% of adult dogs (Canis familiaris), and the
resulting pain presents a significant welfare challenge in the management of older animals [1].
Naturally occurring canine OA is most commonly secondary to joint dysplasia or abnormal
loading forces and progresses over a time course. Canine OA shares developmental, pathologi-
cal and clinical features with human OA [2]. In addition, client owned dogs are likely to be
exposed to similar environmental conditions [3], and potentially lifestyle factors [4], as human
OA sufferers. Spontaneously occurring canine OA has therefore been proposed as a model for
further investigation of, and trial of therapeutics for the human condition, with the potential to
impact both animal and human welfare [5]. If this model is to be optimized, all relevant out-
come measures and measures of the pain state need to be developed and validated, including
measures of central sensitisation.
The development of enhanced nociceptive transmission within the central nervous system
(central sensitisation, CS) is a feature of OA in a subset of human sufferers [6], and may predict
a poor response to present standard of care analgesics [7]. In humans CS can be characterised
by the application of a variety of sensory modalities [7] and the presence of CS is indicated by
secondary mechanical dynamic and punctate hyperalgesia. Central sensitisation has also been
suspected in clinical canine OA patients [8]; however there is presently no standard method of
assessing CS in dogs, therefore the fidelity of the spontaneous canine OA model to human OA
cannot be assured. Furthermore, there is the potential for varying and unknown degrees of CS
to confound the results of therapeutic trials in dogs. Behavioural responses have been assessed
in order to evaluate potential alterations in nociceptive thresholds to heat, pressure, and cold
(quantitative sensory testing, QST) in dogs experiencing OA and have indicated heat hypoalge-
sia [9], mechanical hyperalgesia [10,11] and cold hyperalgesia [11]. Limitations of QST meth-
ods in dogs have been reported as lack of feasibility in some dogs [9,12], effects due to the
temperament and degree of anxiety of the dog [13], and the subjective interpretation of beha-
vioural responses as an end point.
Nociceptive withdrawal reflexes (NWR) were first described as gross unified limb flexion
movements in response to suprathreshold nociceptive stimulation by Sherrington [14]. Subse-
quent work however has characterised responses as co-ordinated activation and inhibition of
both flexor and extensor muscles in a limb, with the resultant co-ordination dependent on the
site of noxious stimulation [15,16]. NWR in individual hindlimb muscles can therefore be
recorded using electromyography (EMG) in order to obtain a quantitative measurement of the
motor response to a peripherally applied stimulus [17] and to study the organization of
responses in individual muscles to stimulation at a particular site. Central sensitisation appears
to enhance the protective movement provided by individual muscle NWRs [18]. Central sensi-
tisation in chronic pain states in humans has been evaluated using NWRmethodology [19],
and CS has been demonstrated via NWR facilitation in experimental animal models of OA
[20]. Measurement of NWRmay be a more objective methodology than QST to gain insight
into central nervous system plasticity in dogs and therefore may have utility in client-owned
dogs with chronic pain conditions, including OA. Nociceptive withdrawal reflex methodology
Alfaxalone and Nociceptive Withdrawal Reflexes in Dogs
PLOS ONE | DOI:10.1371/journal.pone.0158990 July 19, 2016 2 / 18
no role in study design, data collection and analysis,
decision to publish, or preparation of the manuscript.
Competing Interests: The authors have the
following interest: Travel and accommodation
expenses for J. Hunt and JM, and salary costs of J.
Hunt were met from BBSRC grant BB/L00240X/1, for
which Zoetis is the Industry Partner. There are no
patents, products in development or marketed
products to declare. This does not alter the authors'
adherence to all the PLOS ONE policies on sharing
data and materials.
in client-owned dogs would also facilitate clinical trial evaluation of putative analgesics that tar-
get modulation of CS.
Previously published work has assessed NWR in conscious, trained research dogs, but client
owned dogs are likely to be less tractable and artefacts associated with movement are likely to
obscure EMG responses to nociceptive stimuli. Collection of EMG recordings of sufficient
quality, whilst minimising the aversive experience associated with the stimulation (which,
aside from animal welfare considerations, may, in itself, modulate nociceptive transmission
[21,22]) may necessitate anaesthesia in such dogs. Recordings of EMGs elicited by both high
frequency (200Hz) train-of-5 electrical stimuli [23], and lower frequency (2, 5 and 20 Hz)
repeated stimuli [24] have been described in pain free conscious and acepromazine sedated
[25] dogs; and proposed as an objective means of investigating central nervous system plasticity
[25] as well as the effects of analgesic drugs [26]. Previous work has shown that a low dose
(0.01mg kg-1) of acepromazine administered intravenously to experimental dogs produced
mild tranquilisation for approximately 30 minutes and did not alter the characteristics of the
recorded EMG [25]. However acepromazine sedation alone may not be considered to produce
an appropriate degree of anxiolysis prior to the application of repeated nociceptive stimuli to
client owned dogs. Sedation with dexmedetomidine may produce more effective anxiolysis but
would be expected to affect NWR [27]. General anaesthesia would obviate any potential stress
and awareness of nociception associated with NWR protocols, thus refining the procedure. It
would also likely increase owner acceptability of the procedure, particularly if electrical stimuli
are used. Preliminary pilot work investigating the ability to record EMGs in dogs anaesthetised
with isoflurane, indicated that isoflurane concentrations required to prevent arousal abolished
EMG responses in a significant number of tests. Alfaxalone anaesthesia has been employed in
laboratory animal species to facilitate EMG recordings [20]. The specific aim of this current
study was to develop a suitable alfaxalone based anaesthetic protocol for use in client owned
dogs, which would enable us to record EMG data whilst minimizing movement artefact.
The primary outcome measures of this study were the magnitudes of the recorded EMGs;
these were compared in order to determine the effects of sedation or anaesthesia produced by
alfaxalone infusion on the recorded EMG, in comparison with results collected in aceproma-
zine sedated dogs.
Materials and Methods
Seven purpose bred male hound dogs (weight range 25.5–29.2 kg) were used for the NWR/
EMG recordings. The dogs were housed individually within enclosures of dimensions approxi-
mately 1.5 x 4.6 metres, and 2.7 metres high, with enrichment consisting of toys that are
changed out and rotated on a regular basis and standard bedding. The dogs’ exercise and socia-
lisation program consisted of two 30 minute walks each day, outside, and two 20 minute play
and socialization periods each day. The dogs were maintained on a standard complete dog
food and food was withheld for eight hours prior to administration of sedative drugs. Ethical
approval was obtained prior to beginning the study from the North Carolina State University
Institutional Animal Care and Use Committee (IACUC; permit number 13-010-B). The exper-
imental protocol was performed with the dogs restrained or anaesthetised in right lateral
recumbency on a synthetic bedding, beneath which was a circulating warm water blanket and
padded table top. Following completion of EMG recordings, carprofen (4mg kg-1) (Rimadyl,
Zoetis, New Jersey, USA) was administered subcutaneously to treat any ongoing pain associ-
ated with the stimulation and recording protocols. Following completion of these experiments
the dogs continued to be kept at the North Carolina State University Animal Care Facility to
participate in further research projects.
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Placement of EMG recording electrodes
The left pes was rested on a sandbag to support the limb perpendicular to the table top. Stain-
less steel needle recording electrodes (disposable subdermal needle electrode 12 x 0.40 mm,
Natus Neurology Inc. Middleton, WI, USA) were placed transcutaneously, in pairs, into the
belly of the cranial tibial (CT), biceps femoris (BF), and sartorius (SA) muscles of the left pelvic
limb. A ground electrode for each pair of recording electrodes was inserted subcutaneously,
dorsal to the dorsal spinous process of L6. The locations of the electrodes are shown in Fig 1.
The distance between each of the electrodes in the pair was as follows: cranial tibial 18mm;
biceps femoris 21mm; sartorius 21mm. Recording electrodes were connected to an analogue to
digital converter (Powerlab 4/35, AD instruments, Oxford, UK) via separate differential ampli-
fiers (DAM50, World Precision Instruments, Herts, UK) which applied a low pass filter of 10
Hz, high pass filter of 1 KHz, and gain of 1000 to the signal. The resulting digital signal was
captured and recorded using Labchart 8 software (AD instruments, Oxford, UK) run on a
Fig 1. Demonstrating the position of recording electrodes in cranial tibial (CT), biceps femoris (BF) and sartorius (SA) muscles, together with
ground electrode placement subcutaneously over the dorsal lumbar region.
doi:10.1371/journal.pone.0158990.g001
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Toshiba Tecra R850 (Toshiba Europe, 41460 Neuss, Germany) laptop, utilising Windows 7
operating system (Microsoft Corp., USA). Fig 2 is a schematic illustrating the recording con-
nections used to measure NWRs.
Sedation and anaesthesia
All dogs underwent the EMG recording procedure described below in each of three states: ace-
promazine sedation, alfaxalone sedation or alfaxalone anaesthesia.
In the acepromazine sedated state, dogs were administered acepromazine (Acepromazine
Maleate Injection, Boehringer Ingelheim Vetmedica, Missouri, USA) 0.03 mg kg-1 injected
intramuscularly into the lumbar longissimus dorsi, 30 minutes prior to being instrumented for
EMG recording. The alfaxalone sedation state was produced by administration of an intrave-
nous bolus of 1mg kg-1 alfaxalone (Alfaxan, Jurox, Missouri, USA), 30 minutes following ace-
promazine premedication as above. Sedation was maintained by intravenous infusion of
alfaxalone (range 0.044–0.08 mg kg-1 min-1); rate of infusion was adjusted to produce a state in
which dogs assumed lateral recumbency, were non-responsive to quiet auditory stimuli, and
exhibited decreased muscle tone but maintained laryngeal reflexes. Dogs in this state were
Fig 2. Schematic, illustrating recording connections.
doi:10.1371/journal.pone.0158990.g002
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provided with supplemental oxygen at a rate of 1–2 litres min-1 via a close fitting facemask.
The alfaxalone anaesthesia state was achieved by administration of an intravenous bolus of 1–2
mg kg-1 alfaxalone, 30 minutes following acepromazine premedication, as above, injected
slowly until adequate conditions for orotracheal intubation were achieved. Anaesthesia was
maintained by intravenous infusion of alfaxalone; rate of infusion was adjusted to produce a
state in which dogs exhibited depressed muscle tone and laryngeal reflexes, sufficient to main-
tain orotracheal intubation with a cuffed endotracheal tube through which oxygen was deliv-
ered via a circle rebreathing system. The rate of alfaxalone infusion (range 0.075–0.1 mg kg-1
min-1) was adjusted to preserve a slow palpebral reflex. Following completion of EMG record-
ings, alfaxalone infusions were discontinued and dogs were monitored during recovery to the
point that they were able to walk unaided, at which point they were transported in a wheeled
crate back to their kennel. Examination the following day was performed to ensure no evidence
of tissue damage or ongoing pain. Due to technical issues, dog 1 did not undergo testing in the
alfaxalone sedation state and dog 5 did not undergo testing in the alfaxalone anaesthesia state.
Stimulation protocol
Determination of the most sensitive area. Rat tooth forceps were used to deliver a firm
pinch, sequentially to 21 points on the skin (Fig 3) on the plantar aspect of the left pes, whilst
recordings of EMG activity were performed, to determine the most sensitive area (i.e. that
which generated the largest magnitude EMG response) to a mechanical nociceptive stimulus.
This sensitive area was then used to apply further mechanical and electrical stimuli. The results
of this part of the experiment indicated that the most sensitive area was the area just proximal
to the pad of the fourth digit (location 14 on Fig 3), and this area was used in subsequent stimu-
lation protocols.
Mechanical Stimulus Response Curve. In order to construct an EMG stimulus response
curve mechanical stimulation was delivered by the application of von Frey filaments (North
Coast Medical, Inc., California, USA) in ascending weight order; 4, 6, 8, 10, 15, 26, 60, 100, 180
and 300g. Each filament was applied perpendicularly to the skin of the previously defined most
sensitive area of the pes with a force just sufficient to cause the filament to bend. This position
was maintained for 3 seconds, before removing the filament from contact with the skin. The
complete series of von Frey filaments was applied in the same ascending order on a total of 3
occasions, with 5-minute intervals between each train of von Frey stimulation.
Response to Electrical Stimulation. Following completion of mechanical stimulation, a
pair of stimulating needle electrodes (disposable subdermal needle electrode 12 x 0.40 mm,
Natus Neurology Inc. Middleton, WI, USA) was placed into the plantar dermal tissues of the
distal phalanx of the fourth digit, immediately proximal to the proximal edge of the digital pad,
of the left pelvic limb. Electrical stimuli were delivered using a constant current stimulator
from an isolated 100 V source (Stimulus isolator FE180, AD instruments, Oxford, UK).
(i) Electrical Stimulus Response Curve
One stimulus event comprised five 1 ms stimuli (Train-of-5, To5), which were delivered at a
frequency of 100 Hz. In order to construct an EMG stimulus response curve, To5 events were
triggered at 60-second intervals using currents of 0.1 (baseline), 1, 2, 3, 4, 5, 6, 7, 8, 9 and 10
mA. The complete series of stimulating currents were applied in the same ascending order on a
total of 3 occasions, with 5-minute intervals between each occasion.
(ii) Response Stability Testing
For assessment of stability of the EMG response, 10 To5 events were delivered at 60- second
intervals with a fixed current of 10 mA.
(iii) Temporal Summation
Alfaxalone and Nociceptive Withdrawal Reflexes in Dogs
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Fig 3. Diagram of left pes illustrating 21 points assessed for sensitivity by pinching with rat tooth
forceps. L, lateral; M, medial.
doi:10.1371/journal.pone.0158990.g003
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Subsequently, the effect of temporal summation was induced by a stimulus train, compris-
ing eight single 10 mA stimuli delivered at a frequency of 1 Hz. This stimulation protocol was
delivered on three occasions at five-minute intervals.
EMG analysis
The mechanical and electrical stimulus intensity which elicited a greater than baseline ampli-
tude response of CT, was noted and defined as nociceptive threshold. Post recording, 10Hz dig-
ital filtering was applied to the EMG traces, to further decrease movement artefact. EMG
recordings were assessed visually to identify the time intervals which represented an early
(indicative of an A- fibre mediated [23]) and late (consistent with a C- fibre mediated)
response. The early period was defined as 0–100 ms following stimulation, while the late period
was defined as 100–500 ms following stimulation. The integral of the rectified EMG response
was extracted for each stimulus. Natural log(ln) [integral] values were subsequently analysed
using the statistics package MLwiN [28] which allowed the repeated measures structure of the
data to be properly accommodated within the analyses. The statistical model was based on a
structure consisting of an individual measurement within repetition, within each anaesthetic
state, within dog and then the effect of anaesthetic state and magnitude of stimulation (electri-
cal or mechanical) was tested within a general linear model. To test for a non-linear relation-
ship a series of polynomial terms for the stimulation were specified. Terms were retained
within the models if they were significant at α 0.05 and were tested against a change in the
log likelihood using a Chi square distribution. The resulting significant models were presented
as graphs of the ln response plotted against the level of stimulation in order to depict the mean
response to the stimulation.
The effect sizes and P values of the predictor variables included in the final models were tab-
ulated, allowing reconstruction of the figures from the predictive equations.
Duration of testing procedure, and median nociceptive thresholds, were compared between
the three states using Krukal-Wallis test, and Dunn’s multiple comparison test post-hoc.
Results
The median (range) duration of each recording session for each state was 200 (165–270) min-
utes, and there were no differences in recording duration between the three states (P = 0.12).
During acepromazine sedation EMG activity was invariably associated with gross move-
ment with flexion of the hock, stifle and hip. During alfaxalone sedation and anaesthesia EMG
activity was associated with small contractions of the cranial tibial muscle (visible as ‘twitches’).
EMG responses from the biceps femoris and sartorius muscles were infrequently recorded in
all except the acepromazine sedated dogs. However it was possible to reliably and consistently
record EMG responses from the cranial tibial muscle in each dog during each state of sedation
or anaesthesia and so comparisons of data recorded were limited to the cranial tibial muscle.
Tolerability of the protocol
Two dogs exhibited signs of anxiety (lip licking, ears drawn back, attempting to escape) during
the stimulation protocol whilst sedated with acepromazine. Electrode displacement requiring
electrode repositioning was encountered during electrical stimulation in these 2 dogs during
the acepromazine sedated state, due to instances of gross movement, but in none of the dogs
during alfaxalone sedation or anaesthesia. EMG recordings were feasible in the two anxious
dogs following reassurance by handlers.
Alfaxalone and Nociceptive Withdrawal Reflexes in Dogs
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Mechanical nociceptive threshold
Mechanical thresholds for individual dogs in each state, together with group medians, are
shown in Table 1. Both alfaxalone treated groups exhibited significantly higher median
mechanical thresholds (P = 0.01) compared to acepromazine sedated dogs, but thresholds were
not different between alfaxalone groups.
Mechanical stimulation (von Frey) stimulus response curve
The effect sizes and P values of the predictor variables included in the final models are pre-
sented in S1 Table.
Recorded responses increased in magnitude with increasing stimulus weight (S1 Table, Figs
4 and 5). Alfaxalone anaesthesia decreased the magnitudes of the EMG responses recorded
(Fig 5), compared with those recorded in both acepromazine and alfaxalone sedated dogs, and
there was a significant interaction between stimulus weight and state (P =<0.001, S1 Table).
The repetition of the stimulus response curve was not identified as a significant source of
response variability in the final model, indicating that neither sensitisation nor habituation to
the stimulus occurred.
Electrical nociceptive threshold
Electrical nociceptive thresholds for individual dogs in each state, and group medians, are
shown in Table 1. Alfaxalone sedated dogs exhibited significantly higher median electrical
thresholds (P = 0.01) compared to acepromazine sedated dogs, but thresholds were not
different between alfaxalone groups, nor between acepromazine sedated and alfaxalone
anaesthetised dogs. The characteristic response to electrical stimulation is illustrated in
S1 Fig.
Table 1. Mechanical and electrical threshold recordings from the three states. *P = 0.01 compared to acepromazine threshold.
State Dog number Mechanical threshold
g
Median mechanical threshold
g
Electrical threshold
mA
Median electrical threshold
mA
Acepromazine
sedation
1 15 15 2.5 2
2 60 2
3 8 1
4 26 2
5 100 6
6 15 1.5
7 8 2
Alfaxalone sedation 2 300 240* 7 5.5*
3 60 4
4 180 3
5 300 4.5
6 300 8
7 180 6.5
Alfaxalone
anaesthesia
1 300 300* 3 3.5
2 300 10
3 300 7
4 180 2
6 60 4
7 300 2
doi:10.1371/journal.pone.0158990.t001
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Electrical stimulus response curves
Increasing magnitudes of responses to increasing stimulating current were observed in both
early and late responses in all three states (S1 Table, Fig 6A and 6B).
There was a significant interaction between current and state (P =<0.001, S1 Table); whilst
the rate of increase in EMG response with current was initially higher (greater increase in
response per unit increase in stimulus intensity) in acepromazine sedated dogs compared to
alfaxalone treated dogs, the magnitude of EMG responses began to plateau at currents greater
than 6mA in acepromazine sedated dogs, but continued to increase up to the maximal (10mA)
stimulation in both alfaxalone treated groups. Repetition and individual dog were not signifi-
cant causes of variability in response.
Electrical evoked response stability and comparison of EMGmagnitude
between states
The early and late EMG responses were repeatable (there was no significant difference in EMG
magnitude between subsequent stimulus occasions) in acepromazine and alfaxalone sedated
dogs (Fig 7A and 7B). However there was significant variation of the magnitude of early (but
not late) EMG response with occasion in alfaxalone anaesthetised dogs (P = 0.005, S1 Table).
Compared to acepromazine sedated dogs, alfaxalone sedation and anaesthesia significantly
decreased the magnitude of early and late EMG (P = 0.007, S1 Table).
Temporal Summation
The magnitude of the early EMG response (Fig 8A) to the temporal summation stimulation
protocol decreased with increasing occasion number in the acepromazine sedated dogs, yet
remained constant with increasing occasion in both alfaxalone states. The magnitude of the
late EMG response (Fig 8B) increased in all groups at a comparable rate (slopes are parallel).
Compared to the acepromazine sedated group, the magnitude of the early and late EMG
Fig 4. EMG recordings from cranial tibial muscle of dog 3 in response to application of increasing weights of von Frey filaments. Upper trace
following acepromazine sedation, middle trace following alfaxalone sedation and lower trace following alfaxalone anaesthesia. Weights of von Frey filaments
are shown on each trace in grams, thin grey vertical lines represent the period during which stimulation was applied at each weight.
doi:10.1371/journal.pone.0158990.g004
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responses recorded in the alfaxalone sedated and anaesthetised groups was significantly
decreased (P =<0.001, S1 Table).
There was an obvious difference in behavioural response of the dogs in the different states
to temporal summation, with the acepromazine sedated dogs maintaining their stimulated
limb in flexion with repeated delivery of the stimulus.
Discussion
We have demonstrated that it is possible to record robust and repeatable EMGs in response to
mechanical and electrical nociceptive stimuli in dogs administered alfaxalone. This represents
the first investigation of the effect of anaesthetic state on recorded EMG responses in dogs and
Fig 5. Responses to 3 second application of increasing weights of von Frey filament to the plantar skin of
digit 4 in Fig 3.
doi:10.1371/journal.pone.0158990.g005
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provides a methodological platform for future studies examining CS in dogs with naturally
occurring OA pain. Alfaxalone anaesthesia decreased the magnitude of EMGs recorded in
response to mechanical stimuli, and both alfaxalone treatments decreased the magnitude of
EMGs in response to electrical stimuli, compared to EMGs recorded in dogs sedated with ace-
promazine only. However, responses remained readily identifiable, and continued to demon-
strate expected stimulus response and temporal summation characteristics during both
alfaxalone states. Furthermore there were no significant differences between the magnitudes of
response to electrical stimulation between the two alfaxalone treatment groups. Thus, if NWR/
EMG responses are to be recorded in client owned animals, general anaesthesia may be suc-
cessfully employed in order to facilitate recording, and negate the aversive experiences associ-
ated with the stimuli. However, the stability data suggest that the magnitude of EMG response
varies with anaesthetic state, therefore our results indicate that maintaining a stable plane of
Fig 6. Mean EMG responses to electrical stimulus response; early 0-100ms (a) and late 100-500ms (b). Responses of the acepromazine sedated
group are represented by , alfaxalone sedated by □, and alfaxalone anaesthetised by4.
doi:10.1371/journal.pone.0158990.g006
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anaesthesia is critical for NWR/EMG recording, and is most likely to be achieved by continu-
ous rate, or appropriately modelled target controlled, infusion. Generation and recording of
EMG responses to electrical nociceptive stimuli in acepromazine sedated, pain free dogs repli-
cates previous findings [25], supporting the contention that such a technique may be able to be
transferred to the clinical setting to describe nociceptive processing in individual pet dogs.
However behavioural signs, which could indicate anxiety, and electrode displacement resulting
from subject movement, were noted more frequently in this state, which may limit the accept-
ability and utility of the procedure in client owned dogs. The recording protocol required the
dogs to remain in lateral recumbency for 3 hours, which again may be more difficult to achieve
without anaesthesia in client owned dogs, particularly those suffering from painful conditions.
Whilst dog owners routinely consent to potentially aversive diagnostic testing in conscious
dogs (e.g. venipuncture, fine needle aspiration of masses) these are expected to be brief experi-
ences. A more prolonged procedure involving administration of repeated nociceptive stimuli
may be expected to result in increased stress, compared to a momentary single aversive stimu-
lus. Stress may inhibit [21] or potentiate [29] nociception. These psychological states represent
potential confounding factors if NWR/EMG recording is attempted in non-anaesthetised dogs.
Fig 7. Mean EMG responses to electrical stability; early 0-100ms (a) and late 100-500ms (b). Responses of the acepromazine sedated group are
represented by , alfaxalone sedated by □, and alfaxalone anaesthetised by4.
doi:10.1371/journal.pone.0158990.g007
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There are a paucity of data available regarding the degrees of stress and welfare compromise
involved in veterinary diagnostic procedures, however a semi-quantitative approach to assign-
ing values to represent the welfare of dogs with respect to differing treatment options has been
described [30]. A similar approach to assessing welfare impacts of differing diagnostic
approaches could be employed, and in the absence of contra-indications, anaesthesia may rep-
resent a higher welfare method of achieving NWR evaluations.
Recording of EMG responses to nociceptive stimuli has previously been reported in dogs
anaesthetised with isoflurane [27]; however our preliminary pilot work, using the methodology
described above, indicated that isoflurane concentrations required to prevent arousal abolished
EMG responses in a significant number of tests. Other investigators [31] reported that isoflur-
ane anaesthesia depressed heat evoked withdrawal responses in rats, as measured by a force
meter. In humans and ponies, NWR thresholds are significantly increased by isoflurane
[32,33]. Isoflurane produces immobility at inspired concentrations of 0.8–1.2 minimum alveo-
lar concentration, via preferential depression of ventral horn spinal neurones [34]. This prop-
erty may limit its utility as an anaesthetic agent during procedures which require measurement
of motor responses. Alfaxalone has previously been successfully employed as an anaesthetic
agent during EMG recordings in rats [20,35] and, on this basis, was selected for this study in
Fig 8. Mean EMG responses to temporal summation; early 0-100ms (a) and late 100-500ms (b). Responses of the acepromazine sedated group are
represented by , alfaxalone sedated by □, and alfaxalone anaesthetised by4.
doi:10.1371/journal.pone.0158990.g008
Alfaxalone and Nociceptive Withdrawal Reflexes in Dogs
PLOS ONE | DOI:10.1371/journal.pone.0158990 July 19, 2016 14 / 18
dogs. However the effects of this agent on NWR and EMG recordings have not been previously
studied in dogs, and therefore both alfaxalone sedation and alfaxalone anaesthesia were
studied.
Different modalities of nociceptive stimuli may have differing utility in the measurement of
NWR/EMG recordings. Application of punctate mechanical stimuli to the area of the pes
exhibiting highest sensitivity was performed in order to evaluate the responses to a physiologi-
cally relevant noxious stimulus which generates action potentials via activation of A- and C-
fibre mechanically sensitive afferents. Both alfaxalone treatments significantly increased the
threshold force required to elicit a response. In addition, the magnitude of response was
decreased by alfaxalone anaesthesia, compared to acepromazine or alfaxalone sedation. To our
knowledge this is the first study to determine EMG responses to punctate mechanical stimuli
in dogs. Given that central sensitisation results in secondary hyperalgesia to mechanical, but
not heat stimuli [36], assessment of EMG responses to mechanical stimulation may be used as
a specific means of assessing and quantifying central sensitisation [20]. In order to evaluate
mechanical sensitivity in anaesthetised dogs, stimuli of greater magnitude may be necessary.
Application of electrical stimuli represents a quantifiable and widely employed (e.g.
[25,37,38]), but non-physiological, means of eliciting NWRs. Electrical stimulation obviates
the transduction required by physiological stimuli, and depolarises both low and high thresh-
old nociceptive fibres simultaneously [39], in addition to non-nociceptive afferents [40,41].
Such widespread activation of different fibres may itself result in modulation of nociception at
the spinal cord [40]. In acepromazine and alfaxalone sedated states, responses were repeatable,
demonstrating that this protocol represents a stable condition, in which the effects of altering
stimulus parameters can be assessed over the period of the experiment. Unexpectedly, the mag-
nitude of the early response in the alfaxalone anaesthetised dogs varied with occasion (repeat
of the To5). This is a concern, as such an effect may confound determination of NWRs. A 10m
A stimulus was chosen to assess electrical stability on the basis that this would represent a
suprathreshold stimulus. The response stability data for the alfaxalone anaesthetised state was
derived from only 5 of the 7 dogs and the threshold current during alfaxalone anaesthesia in
dog 2 was determined to be 10 mA. Re-examining the EMG recorded from dog 2 it is evident
that a number of stimuli during the response stability testing had produced no response (i.e. 10
mA represented a subthreshold stimulus). Repeating the analysis, following exclusion of the
stability data from dog 2 during the alfaxalone anaesthetised state, demonstrated that the
responses of the remaining alfaxalone anaesthetised dogs were repeatable in this state, and sug-
gests that the protocol should be equally valid in alfaxalone anaesthetised dogs.
Alfaxalone increased the threshold to electrical stimuli, although this was only statistically
significant in the alfaxalone sedated state. Alfaxalone also decreased the magnitude of resulting
EMGs. However the characteristics of increasing responses associated with increasing intensity
of stimuli, allowing the construction of stimulus-response and temporal summation curves,
were maintained. Decreased NWR threshold (i.e. a left shift in the stimulus response curve)
has been reported in human populations experiencing augmented pain as a result of central
sensitisation [19]; the ability to generate stimulus-response curves in pain-free alfaxalone
infused dogs offers potential as a method of investigating central sensitisation in dogs. Further
work to define reference EMGmagnitude values to predetermined increasing electrical stimuli
in normal, non-painful dogs would be beneficial. In all states, increasing late responses (consis-
tent with C-fibre activation) were observed in response to temporal summation, suggesting
this protocol would be suitable for investigating wind-up in alfaxalone infused dogs. The
decreasing early EMGmagnitude with increasing stimulus number in the acepromazine dogs
is likely to reflect the behavioural response—continued maximal flexion of the limb—thus lim-
iting the potential for further muscle contraction. Augmentation of NWR in response to
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temporal summation is regarded as a cardinal feature of central sensitisation, and has been
reported in a number of clinical pain conditions in man [42,43].
Modular organisation of nociceptive withdrawal reflexes [16] produces greatest motor activ-
ity in specific muscles, activation of which would remove the stimulated area from the noxious
stimulus. The most robust recordings in response to stimulation at point 14 were therefore
made from the cranial tibial muscle, which would be the prime mover in flexing the tibiotarsal
joint, removing the foot from the stimulus. It was not possible to record consistent EMG sig-
nals from the biceps femoris and sartorius muscles which are situated more distant to the site
of stimulation. Higher intensity stimulation (e.g. temporal summation) did result in flexion of
the hip and generation of EMG recordings from the sartorius (hip flexor) during acepromazine
sedation, however responses were not observed in this muscle during alfaxalone infusions;
comparisons were not, therefore, performed.
In conclusion, it was possible to record robust and reproducible EMG responses to electrical
stimulation in both the alfaxalone states, and the results of the stimulus response and temporal
summation stimulations were not different between the two states. Performing recordings in
the alfaxalone anaesthesia state does not appear to negatively impact the data collected, and
this state permits tracheal intubation, which is desirable in anaesthetised dogs. Following ace-
promazine premedication, induction of anaesthesia with 1–2 mg kg-1 alfaxalone, followed by a
continuous rate infusion in the range 0.075–0.1 mg kg-1 min-1 has the potential to enable
assessment of spinal nociceptive processing, by applying mechanical and electrical stimulus
response, and electrical temporal summation protocols, in client owned dogs without subject-
ing them to potentially aversive experiences. Altered central nervous system nociceptive pro-
cessing has been identified in a number of chronic pain conditions [44], and a means of
investigating the nociceptive system may assist clinicians in targeting therapeutic interventions
in individual animals.
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